Federal Circuit Poised to Shape Future of Pharmaceutical Patents in Upcoming Hearings

The Federal Circuit is slated to hear pivotal arguments this month in several significant patent cases, including those involving Moderna’s COVID-19 vaccine and a major Johnson & Johnson schizophrenia medication. These proceedings highlight ongoing patent law contentions, with potential ramifications for pharmaceutical giants and their market strategies. Additionally, the Federal Circuit will become a point of discussion in another appeals court case, as Judge Pauline Newman seeks to reverse her suspension, adding another layer of complexity to the month’s legal battles. For further details on these cases, visit the complete article on Law360.